Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Cancer Discov. 2021 Apr;11(4):960-970. doi: 10.1158/2159-8290.CD-20-1376.
Human tumors are composed of diverse malignant and nonmalignant cells, generating a complex ecosystem that governs tumor biology and response to treatments. Recent technological advances have enabled the characterization of tumors at single-cell resolution, providing a compelling strategy to dissect their intricate biology. Here we describe recent developments in single-cell expression profiling and the studies applying them in clinical settings. We highlight some of the powerful insights gleaned from these studies for tumor classification, stem cell programs, tumor microenvironment, metastasis, and response to targeted and immune therapies. SIGNIFICANCE: Intratumor heterogeneity (ITH) has been a major barrier to our understanding of cancer. Single-cell genomics is leading a revolution in our ability to systematically dissect ITH. In this review, we focus on single-cell expression profiling and lessons learned in key aspects of human tumor biology.
人体肿瘤由多种恶性和非恶性细胞组成,形成了一个复杂的生态系统,控制着肿瘤的生物学特性和对治疗的反应。最近的技术进步使我们能够以单细胞分辨率对肿瘤进行特征描述,为剖析其复杂的生物学特性提供了一种极具吸引力的策略。在这里,我们描述了单细胞表达谱分析的最新进展,以及将这些方法应用于临床环境的研究。我们强调了从这些研究中获得的一些关于肿瘤分类、干细胞程序、肿瘤微环境、转移以及对靶向和免疫治疗反应的有力见解。
肿瘤内异质性(ITH)一直是我们理解癌症的主要障碍。单细胞基因组学正在引领我们系统剖析 ITH 的能力的革命。在这篇综述中,我们专注于单细胞表达谱分析以及在人类肿瘤生物学关键方面得到的经验教训。